Jane Freeman

6.0k total citations · 1 hit paper
102 papers, 4.2k citations indexed

About

Jane Freeman is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Jane Freeman has authored 102 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Infectious Diseases, 52 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in Jane Freeman's work include Clostridium difficile and Clostridium perfringens research (70 papers), Microscopic Colitis (38 papers) and Viral gastroenteritis research and epidemiology (30 papers). Jane Freeman is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (70 papers), Microscopic Colitis (38 papers) and Viral gastroenteritis research and epidemiology (30 papers). Jane Freeman collaborates with scholars based in United Kingdom, United States and New Zealand. Jane Freeman's co-authors include Mark H. Wilcox, Simon D. Baines, Warren N. Fawley, Ed J. Kuijper, S. L. Todhunter, C. H. Chilton, Martijn P. Bauer, Abraham Goorhuis, Jeroen Corver and Jon J. Vernon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Jane Freeman

98 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Changing Epidemiology of Clostridium difficile Infections

2010 641 citations Jane Freeman, Simon D. Baines et al. profile →

Peers

Countries citing papers authored by Jane Freeman

Since Specialization

Citations

This map shows the geographic impact of Jane Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Freeman more than expected).

Fields of papers citing papers by Jane Freeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Freeman. The network helps show where Jane Freeman may publish in the future.

Co-authorship network of co-authors of Jane Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Freeman. A scholar is included among the top collaborators of Jane Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Freeman. Jane Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular clock complexities of Clostridioides difficile 2025 ·Anaerobe ·Jon J. Vernon, David W. Eyre, M. H. Wilcox, Jane Freeman	1
2	Clostridioides difficile pathogenesis and control 2025 ·Nature Reviews Microbiology ·C. H. Chilton, Virginie Viprey, (unknown), Inês B. Moura, Anthony M. Buckley, Jane Freeman, (unknown), Mark H. Wilcox	1
3	Hear my voice: involving patients in Clostridioides difficile infection research 2023 ·Clinical Microbiology and Infection ·Judith Strawbridge, John Heritage, Marcela Krůtová, Benoît Guéry, Kerrie Davies, Fidelma Fitzpatrick, Jane Freeman	1
4	Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile 2023 ·mBio ·Kate E. Dingle, Jane Freeman, Xavier Didelot, T. Phuong Quan, David W. Eyre, Jeremy Swann, (unknown), Emma Clark, Keith A. Jolley, A Sarah Walker, Mark H. Wilcox, Derrick W. Crook	9
5	Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance 2023 ·Journal of Biological Chemistry ·(unknown), Darren Greetham, (unknown), Michael P. Williamson, Caroline A. Evans, (unknown), (unknown), Jane Freeman, Georgina Davis, Mark J. Dickman, Mark H. Wilcox, Andrew L. Lovering, Robert P. Fagan, Stéphane Mesnage	6
6	In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile 2023 ·Journal of Antimicrobial Chemotherapy ·Hélène Marchandin, (unknown), Gaëtan Poulen, Jane Freeman, Mark H. Wilcox, Hélène Jean‐Pierre, Frédéric Barbut	26
7	Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile 2021 ·Journal of Antimicrobial Chemotherapy ·(unknown), Igor A. Sidorov, Sam Nooij, Céline Harmanus, (unknown), Virginie Viprey, (unknown), Emma Clark, Kerrie Davies, Jane Freeman, Ed J. Kuijper, Wiep Klaas Smits, Marc J. M. Bonten, Maja Rupnik, (unknown), Evelina Tacconelli, (unknown), (unknown)	36
8	Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study 2019 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Jane Freeman, Jon J. Vernon, (unknown), K. Morris, (unknown), (unknown), Emma Clark, José Palacios, Mark H. Wilcox	57
9	Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars 2018 ·Anaerobe ·(unknown), Jon J. Vernon, Jane Freeman, Mark H. Wilcox, C. H. Chilton	4
10	Predictive Values of Models of Clostridium difficile Infection 2015 ·Infectious Disease Clinics of North America ·C. H. Chilton, Jane Freeman	4
11	Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model 2014 ·Journal of Antimicrobial Chemotherapy ·G. S. Crowther, C. H. Chilton, S. L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, M. H. Wilcox	35
12	Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota 2014 ·PLoS ONE ·G. S. Crowther, C. H. Chilton, S. L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, Mark H. Wilcox	39
13	Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model 2012 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, Jane Freeman, G. S. Crowther, S. L. Todhunter, Mark H. Wilcox	25
14	Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model 2008 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, Rory J O’Connor, Katherine Saxton, Jane Freeman, Mark H. Wilcox	47
15	Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model 2007 ·Journal of Antimicrobial Chemotherapy ·Jane Freeman, Simon D. Baines, (unknown), Mark H. Wilcox	81
16	Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model 2006 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, Katherine Saxton, Jane Freeman, Mark H. Wilcox	67
17	Factors that impact on the application of guidelines in general practice: a review of medical records and structured investigation of clinical incidents in hypertension 2005 ·Quality in primary care ·Moyez Jiwa, Jane Freeman, Colleen Fisher, (unknown), (unknown), James Reid	2
18	Intra-rater and inter-rater reliability of gait measurements with CODA mpx30 motion analysis system 2003 ·Gait & Posture ·Veronica Maynard, A. M. O. Bakheit, Jackie Oldham, Jane Freeman	72
19	Thyroid function in severely traumatized patients with or without head injury 1988 ·European Journal of Endocrinology ·René Chiolero, T Lemarchand-Béraud, Y. Schütz, N. de Tribolet, (unknown), Jane Freeman	41
20	Entry to general practice training. 1983 ·BMJ ·John M. Roberts, Jane Freeman	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact